“IT'S A NIGHTMARE!” That's how one CME provider described the new commercial support process to me. As a reaction to the OIG pharma marketing guidance, legal and compliance departments are now directing funding procedures, disrupting long-standing relationships between sales reps and CME providers, and creating confusing, time-consuming guidelines. Certainly there were — and still are — plenty of problems in the CME system. But fear of lawsuits and government investigation is driving these ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to The Fear Effect, you'll get exclusive access to a large archive of premium content.

Already registered? here.